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Abstract
This study was aimed to investigate the nutritional status and the role of diabetes mellitus in hemodialysis (HD) patients. Anthropometric, biochemical,
and dietary assessments for HD 110 patients (46 males and 64 females) were conducted. Mean body mass index (BMI) was 22.1 kg/m
2 and prevalence
of underweight (BMI<18.5 kg/m
2) was
  12%. The hypoalbuminemia (<3.5 g/dl) was found in 15.5% of the subject, and hypocholesterolemia (<150
mg/dl) in 46.4%. About half (50.9%) patients had anemia (hemoglobin: <11.0 g/dL). High prevalence of hyperphosphatemia (66.4%) and hyperkalemia
(43.5%) was also observed. More than 60 percent of subjects were below the recommended intake levels of energy (30-35 kcal/kg IBW) and protein
(1.2 g/kg IBW). The proportions of subjects taking less than estimated average requirements for calcium, vitamin B1, vitamin B2, vitamin C, and
folate were more than 50%, whereas, about 20% of the subjects were above the recommended intake of phosphorus and potassium. Diabetes mellitus
was the main cause of ESRD (45.5%). The diabetic ESRD patients showed higher BMI and less HD adequacy than nondiabetic patients. Diabetic 
patients also showed lower HDL-cholesterol levels. Diabetic ESRD patients had less energy from fat and a greater percentage of calories from
carbohydrates. In conclusion, active nutrition monitoring is needed to improve the nutritional status of HD patients. A follow-up study is needed 
to document a causal relation between diabetes and its impact on morbidity and mortality in ESRD patients.
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Introduction17)
Hemodialysis (HD) is the most widely used dialysis modality 
worldwide and the number of patients receiving maintenance HD 
has been rapidly increasing in Korea. According to the end-stage 
renal disease (ESRD) registry committee of the Korean Society 
of Nephrology, the total number of HD patients was 585 per 
million population in 2006, representing an increase of 18 times 
since 1986 (ESRD Registry Committee et al., 2006). Despite 
recent advances in our understanding of the uremic state and 
improvements in the science and technology of HD, the prognosis 
for ESRD patients on HD remains poor (Caglar et al., 2002). 
Nutritional status is a major issue in the long-term management 
of HD patients. Good nutritional status is considered the 
prerequisite for the better prognosis of HD patients. Numerous 
studies have focused on the association between nutritional status 
and clinical outcome of HD patients (Avram et al., 1995; 
Goldwasser et al., 1993; Owen et al., 1993). The prevalence of 
malnutrition such as protein-energy malnutrition, underweight, 
hypoalbuminemia, and anemia is reported to be very common 
in HD patients. Direct correlation of PEM and hypoalbuminemia 
with morbidity and mortality in HD patients were reported 
(Bossola  et al., 2005).
  Qureshi  et al. (1998) reported that 
protein-energy malnutrition was more prevalent at the start of 
the study in patients who subsequently died than in survivors.
 
Churchill et al. (1992) also reported a direct correlation between 
the serum albumin levels and morbidity and mortality in 486 
HD patients. 
Several studies have reported that nutritional status of HD 
patients in Korea was poor. Kim et al. (2000) reported that 6.0% 
of the HD patients showed kwashiorkor-type malnutrition and 
75.8% showed mild malnutrition assessed by weight and serum 
albumin levels. Another study
  indicated that 21.3% of HD 
patients were underweight and serum hemoglobin, hematocrit, 
and total lymphocyte were below the normal range (Kim et al., 
2001). Kim et al.
  (1990)
  reported a low value of anthropometric 
parameters and inadequate intakes of protein, energy, and vitamin 
A, B1, B2, and C in HD patients. 
Diabetes mellitus (DM) is considered contributing risk factors 
for ESRD (Raffaitin et al., 2007; Kim et al., 2005). DM is the 
most common cause of ESRD and its prevalence continues to 
increase worldwide (Kobrin, 1998). 
Nutritional status of HD patients needs to be assessed by a 
combination of anthropometric and biochemical indicators rather 
*This  work  was  supported  by  the  second  stage  of  BK21  Project  in  2008.
§ Corresponding  Author:  Wha-Young  Kim,  Tel.  82-2-3277-3093,  Fax.  82-2-3277-2862,  Email.  wykim@ewha.ac.kr302 Nutritional status of hemodialysis patients
than a single measure. Although several studies have reported 
on inadequate nutritional status and its correlates in Koreans HD 
patients, few studies investigated all of anthropometric, biochemical, 
behavioral, and dietary factors of HD patients. In addition, to 
the best of our knowledge, no study has reported the role of 
DM in HD patients in Korea. This study was aimed to investigate 
the nutritional status, and the role of DM in HD patients.
Subjects and Methods
Subjects 
All subjects were ESRD outpatients from general hospitals and 
HD centers who had been referred to a dialysis center in Seoul, 
Korea, for maintenance HD care. Among the 144 patients 
recruited from June 2007 through March 2008, 110 subjects (46 
males and 64 females) agreed to participate and were enrolled 
in this study. The subjects had been on HD 3 times a week for 
at least 3 months before entering this study. Patients with 
advanced senility or dementia were excluded. Ability to give 
informed consent for participation is one of the eligibility criteria 
for enrollment. All patients were informed that there were no 
interventions and no adverse effects with regard to patients’ rights. 
All patients provided written informed
  consent. The median age 
of these patients was 58.6 years old (range, 28-81 y). All patients 
were interviewed individually to obtain information about their 
general characteristics and health behaviors. The primary cause 
of ESRD was reported and documented. We abstracted and 
reviewed the medical charts to obtain the information.
Measurements
For anthropometrics, height and postdialysis weight were 
measured with light clothes and without shoes using an automatic 
height/weight measuring instrument. Body mass index (BMI) was 
calculated as kg/m
2. Triceps skinfold thickness (TSF) was measured 
using a lange skinfold caliper (Cambridge Scientific Inc., Cambridge, 
MD, USA) at 10 minutes after dialysis. Mid-arm circumference 
(MAC) was measured with a plastic measuring tape using standardized 
techniques. Mid-arm muscle circumference (MAMC) was calculated 
as MAC-(0.314×TSF). 
Blood samples were taken from the arterial site of the vascular 
access before starting dialysis and were sent to Eone Reference 
Laboratory (Seoul, Korea) for analysis. Serum concentrations of 
total protein, albumin, blood urea nitrogen, creatinine, triglyceride, 
total cholesterol, HDL-cholesterol, LDL-cholesterol, calcium, 
phosphorous, potassium, sodium, uric acid, and total iron-binding 
capacity were measured using an autoanalyzer (AVIDA 2400, Bayer 
Diagnostics, Giessen, Germany). Hemoglobin concentration was 
measured using a autoanalyzer (XE 2100, TOA Medical 
Electronics, Kobe, Japan) at the clinical laboratory. Systolic and 
diastolic blood pressures were measured using an automatic 
blood pressure calculator (Omron HEM-907, Omron Matsuzaka 
Co. Ltd., Matsuzuka, Japan).
HD adequacy was estimated by Kt/V according to Daugirdas 
(1993) and the urea reduction rate (URR) was calculated using 
the following formulas:
Kt/V = -In (R-0.03)+[(4-3.5R)×(UF/W)]
URR (%)=(1-R)×100 
*R=Post BUN/Pre BUN, UF is ultrafiltration in L, and W is 
the postdialysis weight in kg. 
We used a URR value of 0.65 or a Kt/V value of 1.2 as the 
minimum values to achieve HD adequacy.
Food intake was recorded using a 24-hour recall method for 
two consecutive days including one dialysis day and one 
nondialysis day. The average intake of the two days was 
considered the daily food intake. The portion size picture booklet 
was used to help the patients estimate portion size. Food intake 
data were analyzed using Can-pro 3.0 software (Korean Nutrition 
Society, 2006) and compared with the Dietary Reference Intake 
for Koreans. Energy and protein intake data were compared with 
the Kidney Dialysis Outcome Quality Initiative recommendation 
by the National Kidney Foundation for HD patients. 
Statistical analysis
Data are expressed as mean and standard error (continuous 
variables) or number and percentage (categorical variables). 
Differences between diabetic and nondiabetic ESRD patients 
were evaluated using ANCOVA, after adjustment for age, HD 
duration, and gender, as appropriate. Because serum ferritin and 
triglyceride concentrations had a skewed distribution, these 
variables were log-transformed before analysis. All analyses were 
performed using SPSS program (version 12.0). Significance was 
defined as P <0.05.
Results
General characteristics and health behavior
As shown in Table 1, mean age and duration of HD were 
58.6 years and 5.8 years, respectively. The most frequent primary 
cause of ESRD was DM (45.5%), followed by glomerulonephritis 
(35.5%), and hypertension (4.5%). The proportion of the subjects 
with family history of ESRD was 17.3%. The proportions of 
current alcohol drinkers and current smokers of male subjects 
were 37.0% and 23.9%, respectively. None of females were 
smokers and 15.6% of them were alcohol drinkers. Adequacy 
of HD was assessed by the Kt/V and URR and values were lower 
in males than in females. Levels of Kt/V and URR of male 
subjects were 1.3 and 64.3%, and those of females were 1.6 and 
72.1%, respectively. Ju-Hyun Cho et al. 303
Table 2. Anthropometric variables
Contents All (n=110) Male (n=46) Female (n=64)
Height (cm) 160 ± 0.01 167.9 ± 0.9
1) 154.2 ± 0.7
Weight (kg) 56.7 ± 1.1  63.5 ± 1.5  51.9 ± 1.1
BMI (kg/m
2)
2) 22.1 ± 0.3  22.5 ± 0.5  21.8 ± 0.4
TSF (mm)
3) 14.5 ± 0.5  12.7 ± 0.7  15.8 ± 0.6
MAC (cm)
4) 26.4 ± 0.3  27.1 ± 0.44  26 ± 0.36
MAMC (cm)
5) 21.9 ± 0.3  23.1 ± 0.5  21 ± 0.3
Prevalence (%) 
BMI < 18.5 kg/m
2  13 (11.8)
6)    1 (2.2)  12 (18.8)
18.5≤ BMI< 23 kg/m
2  52 (47.3)   25 (54.3)  27 (42.2)
23≤ BMI < 25 kg/m
2  29 (26.4)   14 (30.4)  15 (23.4)
BMI > 25.0 kg/m
2  16 (14.5)    6 (13)  10 (15.6)
TSF<5 percentile
7)  32 (29.1)    0 (0)  32 (50)
MAMC<5 percentile  20 (18.2)   12 (26.1)   8 (12.5)
1) Mean ± SE.
2) BMI:  Body  mass  index
3) TSF:  Triceps  skinfold  thickness 
4) MAC:  Mid-arm  circumference 
5) MAMC:  Mid-arm  muscle  circumference 
6) N  (%) 
7) The  Korean  Dietetic  Association  (1994).  Guidelines  for  clinical a n d  n u t r i t i o n a l 
management,  p.10-21
Table 1. General characteristics and health behavior
Contents All (n=110) Male (n=46) Female (n=64)
Age (years) 58.6 ± 1.0
1) 56.8 ± 1.8 59.9 ± 1.1
Duration of HD
2) (years)  5.8 ± 0.5  4.8 ± 0.7  6.6 ± 0.6
Primary cause of ESRD
3)
Chronic GN
4)  39 (35.5)  15 (32.6)  24 (37.5)
Diabetes mellitus  50 (45.5)  24 (52.2)  26 (40.6)
Hypertension   5 (4.5)   1 (2.2)   4 (6.3)
Others  16 (14.5)   6 (13)  10 (15.6)
Family history of ESRD
Yes  19 (17.3)   6 (13)  13 (20.3)
No  91 (82.7)  40 (87)  51 (79.7)
Alcohol drinking
Non-drinker  49 (44.5)   6 (13)  43 (67.2)
Current drinker  27 (24.5)  17 (37)  10 (15.6)
Ex-drinker  34 (30.9)  23 (50)  11 (17.2)
Cigarette smoking
Non-smoker  73 (66.4)   9 (19.6)  64 (100)
Current smoker  11 (10)  11 (23.9)   0 (0)
Ex-smoker  26 (23.6)  26 (56.5)   0 (0)
HD adequacy
Kt/V
5)  1.4 ± 0.02  1.3 ± 0.02  1.6 ± 0.02
URR (%)
6) 68.8 ± 0.6 64.3 ± 0.7 72.1 ± 0.5
1) Mean ± SE.
2) HD:  hemodialysis
3) ESRD:  end  stage  renal  disease
4) Chronic  GN:  Chronic  glomerulonephritis
5) K:  dialyzer  urea  clearance  (ml/min)  t:  dialysis  length  (min)  V: v o l u m e  o f  u r e a 
distribution 
6) URR:  Urea  Reduction  Rate
Table 3. Blood profiles and blood pressure 
Contents Normal 
range
1)
All
(n=110)
Male
(n=46)
Female
(n=64)
Total Protein (g/dl) 6.7-8.3   6.7 ± 0.04
2)   6.8 ± 0.1   6.6 ± 0.1
Albumin (g/dl) 3.5-5.3   3.8 ± 0.03   3.8 ± 0.1   3.7 ± 0.1
Blood urea nitrogen 
(mg/dl)
7.8-23  69.4 ± 1.7  69.3 ± 2.5  69.4 ± 2.2
Creatinine (mg/dl)* 0.6-1.5   9.7 ± 0.3  10.8 ± 0.4   8.9 ± 0.3
Uric acid (mg/dl)** 4.0-8.5   7.8 ± 0.2   8.2 ± 0.3   7.5 ± 0.3
Hemoglobin (g/dl)***  13-18    11 ± 0.1    11 ± 0.2  10.9 ± 0.1
TIBC (μg/dl)
3)**** 250-400  249 ± 4.7 255.3 ± 7.2 244.5 ± 6.2
Ferritin (ng/ml)*****  12-333 262.1 ± 49.1 176.5 ± 23.2 326.6 ± 83.6
Potassium (mmol/l) 3.5-5.3   5.4 ± 0.1  5.29 ± 0.1   5.6 ± 0.1
Sodium (mmol/l) 136-148 138.5 ± 0.3 138.8 ± 0.4 138.3 ± 0.5
Calcium (mg/dl) 8.4-10.2   8.8 ± 0.1   8.8 ± 0.1   8.8 ± 0.1
Phosphorus (mg/dl) 2.5-5.6   5.2 ± 0.2   5.1 ± 0.3   5.2 ± 0.2
Triglyceride (mg/dl)** 130-230 114.8 ± 6.4 115.7 ± 11.5 114.1 ± 7.4
Total cholesterol (mg/dl) 150-240 157.2 ± 3.3 144.9 ± 5.2 166.0 ± 4
HDL cholesterol (mg/dl)**  40-75  45.0 ± 1.6  42.7 ± 2.6  46.7 ± 1.9
LDL cholesterol (mg/dl)** <130  83.5 ± 3.1  74.9 ± 5.1  89.8 ± 3.8
Systolic blood pressure 
(mmHg)
151.6 ± 2.4 156.1 ± 3.2 148.4 ± 3.5
Diastolic blood pressure 
(mmHg)
 81.6 ± 1.2  84.5 ± 1.8  79.5 ± 1.5
Prevalence (%) 
Hypoalbuminemia 
(< 3.5 g/dl)
  17 (15.5)
4)    5 (10.9)   12 (18.8)
Hypocholesterolemia 
(<150 mg/dl)
  51 (46.4)   31 (67.4)   20 (31.3)
Anemia 
(hemoglobin: <11.0 g/dL)
  56 (50.9)   27 (58.7)   29 (45.3)
Hyperphposphatemia 
(phosphorus>4.5 mg/dl)
  73 (66.4)   30 (65.2)   43 (67.2)
Hyperkalemia 
(potassium>5.5 mmol/l)
  20 (43.5)   35 (54.7)   55 (50)
1) Henry's clinical diagnosis and management by laboratory methods.21th ed. W.B. 
Saunders,  2007
2) Mean ± SE. 
3) TIBC:Total  iron  binding  capacity
4) N  (%)
* males=44,  female=64,  ** males=35,  femal=48  ,  *** males=46,  female=63, 
**** males=38,  female=55,  ***** males=46,  female=61
Anthropometric variables
Table 2 shows anthropometric variables of the subjects. Mean 
height, weight, BMI were 167.9 cm, 63.5 kg, and 22.5 kg/m
2 
for male patients, and 154.2 cm, 51.9 kg, and 21.8 kg/m
2  for 
female subjects, respectively. According to the BMI cutoffs for 
Asian adults by the WHO Asia-Pacific guideline, 13 subjects 
(11.8%) were underweight (BMI<18.5 kg/m
2), whereas 16 
subjects (14.5%) were obese (BMI≥25 kg/m
2). Mean values of 
TSF, MAC, and MAMC were 12.7 mm, 27.1 cm, and 23.1 cm
 in 
males, and 15.8 mm, 26 cm, and 21 cm in females, respectively. 
Compared to reference values for Korean adults,
  none of male 
subjects belonged to TSF<5
th percentile, however, 50% of female 
subjects belonged to this category. Also 26.1% of male subjects 
and 12.5% of the female subjects had MAMC<5
th percentile.
Blood profiles and blood pressure 
Table 3 shows blood profiles and blood pressure levels of the 
subjects. The serum concentrations of total protein, albumin, 304 Nutritional status of hemodialysis patients
Table 4. Nutrient intakes of the subjects
Contents All (n=110) Male (n=46) Female (n=64)
Energy (kcal) 1479.9±38.2
1) 1677.5 ± 58.5 1337.8 ± 42.5 
Energy (kcal)/ 
IBW (kg)
27.1 ±0.6 (67.3)
2) 27.5 ± 1.0
  (63) 26.8 ± 0.8 (70.3)
Protein (g) 60.1 ± 1.8 60.7 ± 1.5  59.6 ± 1.3 
Protein (g)/
IBW (kg)
1.1 ± 0.03 (63.6) 1.1 ± 0.05 (58.7) 1.1 ± 0.04 (65.6)
Carbohydrate (g) 218 ± 5.6 218.8 ± 4.5 217.4 ± 3.8
Fat (g) 41.6 ± 1.8 41.8 ± 1.8 41.4 ± 1.5 
Cholesterol (mg) 261.9 ± 13.6 252.7 ± 20.7 268.6 ± 17.2
Calcium (mg) 433.5 ± 18.8  444.8 ± 26.5  425.4 ± 22.1 
Phosphorus (mg) 797.3 ± 23.4  807.9 ± 22.6  789.8 ± 18.8 
Sodium (mg) 3584.3 ± 111.7 3720.8 ± 149.7 3486.1 ± 124.9 
Potassium (mg) 2111.3 ± 67.8 2165.9 ± 78.6 2072.1 ± 65.6
Iron (mg) 11.6 ±0.6 (15.5)
3) 11.6 ± 0.8 (8.7) 11.6 ± 0.7 (21.9)
Zinc (mg) 7.4 ± 0.2 (43.6) 7.4 ± 0.2 (37) 7.4 ± 0.2 (48.4)
Vitamin A (μgRE) 627.2 ± 32.7 (29.1) 609.5 ± 50.7 (30.4) 639.8 ± 42.3 (28.1)
Vitamin B1 (mg) 1.0 ± 0.04 (60) 0.9 ± 0.05 (56.5) 1.0 ± 0.04 (62.5)
Vitamin B2 (mg) 0.9 ± 0.03 (80.9) 0.8 ± 0.04 (82.6) 0.9 ± 0.03 (79.7)
Vitamin B6 (mg) 1.8 ± 0.06 (17.3) 1.8 ± 0.07 (8.7) 1.9 ± 0.06 (23.4)
Vitamin C (mg) 77.8 ± 4.9 (60) 78.7 ± 6.9 (60.9) 77.2 ± 5.8 (59.4)
Vitamin E (mg) 13.4 ±0.6 14 ±0.7 13 ±0.6
Folate (μg) 181.78 ± 6.9 (95.5) 179.6 ± 9.9 (97.8) 183.3 ± 8.3 (93.8)
Energy distribution
% Carbohydrate 59.5 ± 0.8 58.7 ± 1.1 60.1 ± 1.0
% Protein 16.2 ± 0.3 16.4 ± 0.4 16.1 ± 0.3
% Fat 24.7 ± 0.7 25.8 ± 1.1 23.8 ± 0.9
1) Mean ± SE.  Assessed  by  CAN  pro  3.0  program 
2) ( ) : The proportion of subjects taking less than 30 kcal/ IBW (kg)/d for energy 
and  1.2  g/  IBW  (kg)/d  for  protein
3) ( )  :  The  proportion  of  the  subjects  taking  less  than  Estimated  Average 
Requirements  (EAR)  of  Dietary  Reference  Intakes  for  Korean  (KDRI),  wherever 
applicable 
Table 5. Clinical and laboratory data of HD patients with DM and nonDM
Variables DM (n=54) nonDM (n=56) P
BMI (kg/m
2) 2 3 . 0 ± 0 . 4 * *
1)  21.2 ± 0.4 0.005
HD adequacy
  spKt/V    1.4 ± 0.02**   1.5 ± 0.02 0.003
  URR (%)   67.4 ± 0.5***  70.3 ± 0.5 0.0004
Hematological 
  TIBC (μg/dL) 241.9 ± 6.8 256.4 ± 7 0.158
  Creatinine (mg/dL)   9.2 ± 0.3  10.2 ± 0.3 0.067
  Uric acid (mg/dL)   7.5 ± 0.3   8.1 ± 0.3 0.117
  Total cholesterol (mg/dL) 151.1 ± 4.7 163.1 ± 4.6 0.090
  HDL-cholesterol (mg/dL)  41.4 ± 2.2*  49.1 ± 2.3 0.026
  Triglyceride (mg/dL) 126.2 ± 9.3 101.8 ± 9.9 0.091
  LDL-cholesterol (mg/dL)  77.7 ± 4.3  90.2 ± 4.6 0.065
Energy (kcal)/IBW (kg) 26.01 ± 0.9  28.0 ± 0.9 0.162
Protein (g)/IBW (kg)   1.0 ± 0.05   1.1 ± 0.05 0.138
Energy distribution
  % Carbohydrate  61.6 ± 1.1*  57.5 ± 1.1 0.016
  % Protein  16.0 ± 0.4  16.4 ± 0.4 0.570
  % Fat  22.5 ± 1.0**  26.8 ± 1.0 0.004
1) Mean ± SE. P value by ANCOVA between DM and nonDM group after adjusting 
for  sex,  age  and  hemodialysis  duration
*p<0.05,  **p<0.01,  ***p<0.001
blood urea nitrogen, creatinine, and uric acid were 6.8 g/dl, 3.8 
g/dl, 69.3 mg/dl, 10.8 mg/dl, and 8.2 mg/dl, respectively for 
males, and 6.6 g/dl, 3.7 g/dl, 69.4 mg/dl, 8.9 mg/dl, and 7.5 mg/dl, 
for females. The prevalence of hypoalbuminemia (albumin<3.5 
g/dl) was 10.9% in males and 18.8% in females. Hemoglobin, 
ferritin, and TIBC were 11 g/dl, 176.5 ng/ml, and 255.3 μg/dl 
in male subjects, and 10.9 g/dl, 326.6 ng/ml, and 244.5 μg/dl 
in female subjects, respectively. About half of the subjects 
(50.9%) had anemia (hemoglobin: <11 g/dL). In male subjects, 
serum concentrations of potassium, sodium, calcium, and phosphorus 
were 5.29 mmol/l, 138.8 mmol/l, 8.8 mg/dl, and 5.1 mg/dl, 
respectively. The corresponding concentrations for female subjects 
were 5.6 mmol/l, 138.3 mmol/l, 8.8 mg/dl, and 5.2 mg/dl, 
respectively. The prevalence of hyperphosphatemia (phosphorus
≥4.5 mg/dl) was 65.2% in males and 67.2% in females. The 
prevalence of hyperkalemia (potassium≥5.5 mmol/l) was 54.7% 
in males and 50% in females.
The serum levels of triglyceride, total cholesterol, HDL 
cholesterol, and LDL cholesterol were 115.7 mg/dl, 144.9 mg/dl, 
42.7 mg/dl, and 74.9 mg/dl, respectively in male patients, and 114.1 
mg/dl, 166 mg/dl, 46.7 mg/dl, and 89.8 mg/dl in female subjects. 
The prevalence of hypocholesterolemia (total cholesterol<150 
mg/dl) was 67.4% in males and 31.3% in females. Only one 
female patient had a serum cholesterol level over 240 mg/dl. 
Mean diastolic blood pressure was within normal range, however, 
systolic blood pressure was above normal range for both genders. 
Dietary intakes
The subjects’ mean daily nutrient intakes are shown in Table 
4. The intakes of energy, carbohydrate, protein, and fat were 
1677.5 kcal, 218.8 g, 60.7 g, and 41.8 g in males and 1337.8 
kcal, 217.4 g, 59.6 g, and 41.4 g in females, respectively. Energy 
distribution of carbohydrate: protein: fat was 58.7%: 16.4%: 
25.8% in male patients and 60.1%: 16.1%: 23.8% in female 
subjects. The proportions of subjects whose intake did not meet 
energy (30 kcal/kg IBW/d) and protein (1.2 g/kg IBW/d) 
recommended by the Kidney Dialysis Outcome Quality Initiative 
by the National Kidney Foundation
  were 63% and 58.7% in 
males, and 70.3% and 65.6% in females, respectively. 
Dietary vitamin and mineral intakes were not adequate. Sixty 
to eighty percent of subjects did not meet the Estimated Average 
Requirements (EAR) of dietary reference intakes for Korean for 
vitamin B1, vitamin B2, and vitamin C. Almost all patients (96%) 
did not meet the EAR for folate. The proportions of subjects 
taking less than the EAR for iron, vitaminB6,, and vitamin A 
were 15-20%.
Characteristics of HD patients according DM
Patients with DM were compared with patients with nonDM 
to investigate the role of DM in ESRD patients. The average 
BMI was greater in diabetic HD patients than in nondiabetic HD Ju-Hyun Cho et al. 305
patients (P=0.005). Diabetic patients had less fat intake (P=0.004), 
a greater percentage of calories from carbohydrate (P=0.016) and 
lower HDL-cholesterol levels (P=0.026). The diabetic ESRD 
patients showed less HD adequacy than nondiabetic patients 
(spKt/V, P=0.003; URR, P=0.0004).
Discussion
Nutritional assessment and management has been recognized 
as an important therapeutic approach for HD patients, because 
poor nutritional status is associated with poor prognosis in HD 
patients. Many studies have reported the association between 
malnutrition (indicated by low BMI, low body fat, and low 
muscle mass) and mortality in HD patients (Aoyagi et al., 2001; 
Kutner & Zhang, 2001; Port et al., 2002). Several studies reported 
that BMI levels of <19-20 kg/m
2 in HD patients were associated 
with higher mortality risk (Leavey et al., 1998; Mafra et al., 
2007). In our subjects, the mean BMI was in normal range, 
however, the prevalence of underweight (BMI <18.5 kg/m
2) was 
12%. Even higher underweight prevalence of 21.3% in 5,161 
Korean HD patients was reported by Ahn and Choi (1999). We 
employed TSF as an indicator of fat mass and MAMC of muscle 
mass. Our subjects showed high prevalence of low fat mass 
measured by TSF (29.1 %) and low muscle mass measured by 
MAMC (18.2 %). Our result is consistent with other reports that 
fat mass (86.7%) and lean body mass (66.7%) were reduced in 
HD patients (Kim & Kim, 2001; Oksa et al., 1991). 
Hypoalbuminemia, hypocholesterolemia, and anemia were 
considered indicators of malnutrition and predictors of increased 
morbidity and mortality in HD patients. (Kalantar-Zadeh et al., 
2003; Marce´n
  et al., 1997). In this study, 10.9% of males and 
18.8% of females were hypoalbuminemic. The prevalence of 
hypoalbuminemia was similar to the prevalence of underweight. 
Almost all patients (over 90 %) had anemia, assessed by serum 
albumin and hemoglobin. Hypocholesterolemia is common in HD 
patients and is considered an independent predictor of mortality 
in patients on HD. Several studies have reported that HD patients 
with low cholesterol levels were at higher risk of malnutrition 
(Iseki et al., 2002; Okumura et al., 1999; Wakugami et al., 1998). 
In accordance with other reports, our subjects also showed high 
prevalence of hypocholesterolemia (cholesterol<150 mg/dl): 67.4% 
in males and 31.3% in females. 
Relatively high energy and protein intakes have been 
recommended for HD patients because of dialytic losses of amino 
acids, metabolic acidosis, and comorbid conditions.
  The intakes 
of energy and protein were below the recommended level in our 
subjects. The inadequate intake of energy and protein was also 
reported by Kim et al. (2000) in Korean HD patients. Inadequate 
intake of energy and protein in HD patients were also reported 
by Morais et al. (2005) in Brazlian HD patients,
  and by the 
HEMO study in the U.S. HD patients (Rocco et al., 2004). 
Energy and protein deficit is a common nutritional problem in 
HD patients. 
Vitamin and mineral intakes of our subjects were also 
insufficient. The proportions of subjects who did not meet the 
EAR for vitamins and minerals were very high. This result is 
consistent with previous reports in Korean HD patients: Kim et 
al. (2000) reported inadequate intakes of vitamin A and vitamin 
B1; and Chun (2001)
  has reported insufficient intakes of vitamin 
A, vitamin B1, vitamin B2, and niacin. Kalantar-Zadeh et al. 
(2002) reported that HD patients in the U.S. were consuming 
insufficient amounts of vitamin C, dietary fibers and potassium 
in comparison to control subjects. Increased nutrient losses due 
to the dialysis procedures and decreased food intakes due to 
anorexia, psychosocial conditions, depression, and aging are 
contributors for malnutrition in HD patients.
Even though the mean serum concentrations of phosphorus and 
potassium were at upper limit of normal ranges in our subjects, 
the prevalence of hyperphosphatemia (66.4%) and hyperkalemia 
(43.5%) were high. Restrictions on dietary phosphorus and 
potassium have been recommended to control serum levels of 
phosphorus and potassium in HD patients.
  Because high 
phosphorus intake may lead to hyperphosphatemia, secondary 
hyperparathyroidism, and renal osteodystrophy in HD patients, 
it is recommended that dietary phosphorus be restricted to under 
1000 mg/day (Şanlier & Demircioğlu, 2007). In our subjects, 
the average phosphorus intake was 797.3 mg/day, however, 
19.1% of our subjects had a phosphorus intake≥1000 mg/day, 
suggesting the need for phosphorus intake being monitored 
continuously.
  Hyperkalemia is related to irregular heartbeat and 
even death in HD patients (Beto & Bansal, 2004). A recommendation 
is made to restrict
  dietary potassium to under 2000-3000 mg/day 
(National Kidney Foundation, 2003).
 
Dialysis adequacy is a crucial element in the overall management 
of HD patients (Teixeira Nunes et al., 2008).
  Teixeira Nunes 
et al. (2008) reported that dialysis adequacy was related to 
nutritional status and influenced by the protein intake and body 
compositions.
  In this study, levels of Kt/V were 1.3 in males 
and 1.6 in females and were in normal ranges. Kt/V levels were 
lower in males than in females. 
Diabetes mellitus (DM) is considered contributing risk factors 
for ESRD (Kim et al., 2005; Raffaitin et al., 2007). DM is the 
most common cause of ESRD and its prevalence continues to 
increase worldwide (Kobrin, 1998) and in Korea (Kim et al., 
2003). About half of our patients had DM. The prognosis of 
diabetic ESRD patients was worse compared to non-diabetic 
patients, even though duration on HD was shorter (data not 
shown). Diabetic ESRD patients as compared to non-diabetic 
patients showed a significantly higher BMI and lower serum 
HDL cholesterol, Kt/V and URR. Our result is consistent with 
other reports. (Kim et al., 2005; Noel et al., 2002).
The main cause of death in ESRD patients is cardiovascular 
diseases. Hypertension, which is an independent and strong risk 
factor for cardiovascular diseases, was more prevalent in diabetic 
ESRD subjects in our sample. This result emphasizes the 306 Nutritional status of hemodialysis patients
importance of DM patient care to prevent DM-related morbidity 
and mortality. 
In conclusion, the nutritional status of our subjects was 
inadequate, assessed by anthropometric, hematologic, and dietary 
parameters. Therefore, active nutrition monitoring is needed to 
improve the nutritional status of HD patients. Also a follow-up 
study is needed to document a causal relation between diabetes 
and its impact on morbidity and mortality in ESRD patients. 
Further research with a larger sample and for a longer follow 
up period should be conducted to expand our understanding of 
nutritional status for HD patients.
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